InvestorsHub Logo
Followers 127
Posts 5371
Boards Moderated 0
Alias Born 06/09/2020

Re: Grip it and Sip It post# 486064

Monday, 06/13/2022 8:55:43 AM

Monday, June 13, 2022 8:55:43 AM

Post# of 688868
We are derisked. 100%

Waiting is the only suffering left. Things are happening in England. Linda Powers talking to politicians, Bosch and Liau there.

Embrace for impact.

https://insiderfinancial.com/feuersteins-flab-on-northwest-bio-nwbo-dives-stock-on-meritless-claims-after-nailing-primary-endpoint/183278/

Northwest Biotherapeutics (OTCMKTS: NWBO) is now a risk-off biotech trading at a significant discount; in a “sell the news” market, there are no more milestones to sell as the company completed its phase 3 trial successfully and met its primary endpoint.

NWBO is extremely undervalued for a company that has a treatment that could very well become the standard of care for glioblastoma patients after a 17 year hiatus since the last advance in treatment for these cancer sufferers. NWBO is scaling up manufacturing in anticipation of approval.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News